CBNGO00046—The core building block of glycoprotein engineering and glycosylation research 2168523-18-8

In the fields of glycobiology and biopharmaceuticals, glycosylation modifications are crucial to the structure, stability and function of proteins. As a key glycosylation intermediate, GlycanOxazoline is increasingly becoming an indispensable tool in glycoprotein engineering, enzymatic glycosylation synthesis and the development of new carbohydrate drugs. Among them, compound CBNGO00046, with its clear chemical structure and properties, provides a high-purity material basis for related research and transformation applications.

Chemical Information

Chemical name: CBNGO00046 (Glycan Oxazoline derivative)

Common name: Glycan Oxazoline

Chemical formula: C20H33NO17S

Molecular weight: 591.53 g/mol

CAS number:

2168523

-18-8

Structural features

The structural core of Glycan Oxazoline lies in its oxazoline ring, which is a five-membered heterocyclic ring composed of oxygen atoms, nitrogen atoms and three carbon atoms. In CBNGO00046, the oxazoline ring is covalently linked to a specific oligosaccharide chain (characterized by the chemical formula C20H33NO17S), forming a unique glycosyl donor architecture.

l Stable cyclic structure: The cyclic tension of the oxazoline ring and its electron distribution enable it to show significant kinetic stability under specific conditions (such as neutral or weakly acidic environments), but it can also serve as an efficient reaction precursor in an enzyme catalytic environment.

l Efficient glycosylation ability: As a preferred substrate for glycosyltransferases (especially endoglycosidases and their engineered variants), this structure can accurately and efficiently transfer the connected oligosaccharide chains to specific acceptance sites of proteins, peptide chains or other sugar chains (such as asparagine-linked sugar chains, N-glycan chains) through the "transglycosylation" reaction to achieve site-specific glycosylation modification. This mechanism avoids the complex protective group operations in traditional chemical glycosylation and has good stereo and regioselectivity.

l Structural flexibility: The connected oligosaccharide chains (containing sulfur elements, which may involve sulfation modification or special sugar units) can be customized to simulate the diversity and function of natural sugar chains, such as high-mannose, complex or hybrid N-glycans.

Main applications and advantages

Key materials for the preparation of homogeneous glycoproteins

In the biopharmaceutical field, the glycosylation pattern of therapeutic proteins (e.g., monoclonal antibodies, enzyme replacement therapy drugs) directly affects their efficacy, half-life, and immunogenicity. By using Glycan Oxazoline with a well-defined structure such as CBNGO00046 as a glycosyl donor, uniform and designed sugar chains can be accurately installed into specific sites of proteins through enzymatic reconstruction. This method can overcome the problem of glycosylation heterogeneity in native expression systems and provide a reliable path for the production of next-generation biopharmaceuticals with optimized pharmacodynamic properties.

Core reagents for glycosylation mechanism research and tool development

This compound is an ideal probe molecule for in-depth study of the catalytic mechanism, substrate specificity and kinetic parameters of glycosyltransferases and glycoside hydrolases (especially endoglycosidases). By studying its interaction with enzymes, the molecular details of glycosylation and deglycosylation can be revealed, thereby guiding enzyme engineering and developing glycoengineering tool enzymes with higher efficiency and specificity. In addition, Glycan Oxazoline-based probes can also be used to label and detect glycosylation processes or specific glycoproteins on the cell surface.

The cornerstone of the discovery of new carbohydrate vaccines and glycosylated drugs

Unique carbohydrate antigens or abnormal glycosylation on the surface of pathogens are important markers of diseases such as cancer. The structurally controllable glycosyl oxazolines represented by CBNGO00046 provide modular building blocks for the efficient synthesis of these key sugar epitopes. These synthetic antigens could be used to develop safer and more effective glycoconjugate vaccines (e.g., antibacterial or antitumor vaccines). At the same time, by introducing specific sugar chains into small molecule drugs or nucleic acid drugs, their water solubility, targeting and in vivo stability can be improved, opening up a new frontier in glycosylation medicinal chemistry.

Fundamental components for chemical glycobiology and diagnostic applications

At the basic research level, this compound can be used to construct glycochips, glycopolymers or glycodendrimers with well-defined structures to systematically study sugar-protein interaction networks (such as lectin recognition). These studies are crucial for understanding cell communication, immune responses and disease occurrence. In addition, specific sugar chain structures related to diseases are expected to serve as biomarkers in the future, and the synthesis method based on Glycan Oxazoline is the key to obtaining these standards for the development of diagnostic methods.

Conclusion

From decoding the basic functions of the glycocode in living systems to driving the creation of glycosylated precision medicine products, Glycan Oxazoline represents an important bridge between basic glycoscience and translational applications. As a clear example of this type of molecule, CBNGO00046's value lies not only in providing a chemical reaction intermediate, but also in that it enables researchers to manipulate glycosylation, a key post-translational modification, in a controllable and efficient manner, thus opening up new possibilities in multiple frontier fields such as regenerative medicine, immunotherapy, and anti-infective drugs.

The above information is provided by the editor of KASONS and is for scientific research only.